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1. Introduction 
Achilles tendinopathy is a common condition that has a relatively high morbidity in both 
the general population and in athletes. The most commonly used and accepted theory is that 
it is a degenerative tendinopathy caused by relative overuse in weightbearing activities, and 
this is especially the case in chronic cases. In the early stages of symptoms it is more likely 
that there will be no obvious degenerative changes and this has been termed tendinosis and 
is considered reversible. Achilles tendinopathy can be a difficult condition to treat, 
especially when it is chronic, and it is important to address causative factors in the 
management of this condition to ensure symptom reduction and minimize the risk of 
recurrence. In order to do this, a sound knowledge of anatomy and pathophysiology is 
required to accurately assess the musculoskeletal regions impacting on the loading of the 
Achilles tendon. As with all tendinopathies, the basic principles of evidence based exercise 
rehabilitation should be the mainstay of treatment. All other therapies should be used as 
adjuncts to this. Many medications can be trialed as therapy is more recalcitrant cases, but 
caution must be used to weigh the known risks and benefits and “first do no harm” 
(“primum nil nocere”). Achilles tendinopathy is a condition that can be frustrating to treat 
and requires careful management and patience to ensure optimal outcomes. 
2. Anatomy 
The Achilles tendon is a large strong tendon that joins the calf muscle to the posterior aspect 
of the calcaneus. The gastrocnemius muscle is formed from two heads that arise from the 
posterior femur above the knee joint and join in the calf with the soleus muscle, which arises 
from the posterior tibia and fibula below the knee joint. These two muscles merge to form 
the Achilles tendon in the mid-calf. The gastrocnemius and soleus muscles and their 
tendoAchilles are the primary ankle plantarflexors. The soleus component of the Achilles 
tendon twists medially as its approaches the Achilles insertion and, occasionally, an 
accessory soleus muscle is present and inserts onto the posteromedial calcaneus separate to 
the Achilles tendon. 
At the insertion onto the posterior calcaneus there are two bursae associated with the 
Achilles tendon, the retrocalcaneal bursa that slides in the angle between the 
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posterosuperior calcaneal border and the anterior aspect of the distal Achilles tendon 
(Figure 1), and the retroAchilles bursa that slides between the posterior Achilles tendon at 
its insertion and the overlying skin and subcutaneous tissue. These bursae have a 
lubricating function to reduce friction during ankle movement, but can become involved in 
the pathologic process. 
 
Fig. 1. MRI sagittal image demonstrating the Achilles tendon anatomy. The arrow indicates 
the Achilles tendon (black) inserting onto the posterosuperior calcaneus and also shows a 
small fluid collection in the retrocalcaneal bursa (white) between the anterior aspect of the 
Achilles tendon and the posterosuperior calcaneus. 
The Achilles tendon is surrounded by a fine sheath, the paratenon, that is not a synovial 
sheath but has lubrication and friction reduced properties. It is recognized that the 
paratenon may be involved in the pathologic process of Achilles tendinopathy, and may 
contribute to loss of friction reduction and potentially increased tendon fibre strain and thus 
degeneration. 
3. Pathophysiology 
Tendons are relatively slow metabolically, with approximately 10-13% of the oxygen uptake 
of muscle. Tendons heal at a slower rate than muscle and take approximately 100 days (over 
3 months) to form biomechanically strong collagenous scar tissue with enough tensile 
strength and elasticity to accept the forces applied to the Achilles tendon during heavy 
weightbearing activity such as running or jumping. This slow metabolic rate and slow 
healing rate have implications for treatment of the Achilles tendon in order to prevent injury 
recurrence. 
Chronic Achilles tendinopathy is almost exclusively a degenerative tendinopathy with 
histopathologic features of collagen fibre disruption and disorientation (fibre tearing), 
mucoid degeneration, new blood vessel formation (neovascularisation), and an absence of 
inflammatory cells. It is due to the absence of inflammatory cells histopathologically that the 
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general descriptor “tendinopathy” is now preferred to the inflammatory descriptor 
“tendonitis”. It should, however, be recognized that the histopathologic description above 
applies to chronic tendinopathy and it is possible, some may say highly likely, that is the 
acute stages of Achilles tendon injury there is an inflammatory component in the paratenon 
and possibly the tendon itself. There may also be symptoms with pathologic changes, this is 
termed “tendinosis”, and is considered a reversible condition due to the lack of observed 
tendon changes. 
Achilles tendinopathy is classified into two types, insertion Achilles tendinopathy that is 
commonly associated with bursitis, and non-insertional Achilles tendinopathy that is 
classically location in the relatively hypovascular “watershed” region of the tendon 4-6 cms 
from the calcaneal insertion. Non-insertional Achilles tendinopathy is rarely associated with 
bursitis but may have more of an element of paratenon involvement. Recent research has 
suggested a genetic association between the COL1A1 gene locus and the development of 
non-insertional Achilles tendinopathy in Caucasian populations in South Africa and in 
Australia. Other suggested risk factors for the development of Achilles tendinopathy 
include both intrinsic and extrinsic factors (Table 1). Many of these risk factors and their 
cause and effect relationship with Achilles tendinopathy remain to be scientifically tested 
and proven.  
 
Intrinsic Risk Factors Extrinsic Risk Factors 
Genetics (COL1A1)
 
Biomechanical abnormalities: 
leg length discrepancy 
subtalar hyperpronation 
muscle asymmetry/ tightness 
joint asymmetry/ stiffness 
joint instability 
(e.g. lateral ankle laxity, peroneal 
subluxation) 
 
Rheumatic disease: 
rheumatoid arthritis 
psoriatic arthritis 
 
Collagen disorders 
 
Metabolic disorders 
Training
Insufficient warm-up/ stretching 
training frequency 
training intensity 
training duration 
training volume 
monotony of training 
cross-training 
 
Surfaces 
slopes/ hills/ cambered surfaces 
change to hard or soft surface 
unstable surface (e.g. soft sand) 
 
Equipment 
footwear 
rackets in rackets sports 
 
Nutrition 
Inadequate carbohydrates/ protein 
Inadequate hydration during exercise 
 
Medications: 
- flouroquinolones (e.g. ciprofloxacin) 
-  anabolic steroids 
Table 1. Suggested intrinsic and extrinsic risk factors for Achilles tendinopathy. 
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It may be that a combination of intrinsic risk factors such as muscle or joint asymmetry of 
subtalar hyperpronation, when combined with relative overuse of the tendon through 
repetitive loading and microtrauma, lead to the development of Achilles tendinopathy. Of 
course, in general, it is difficult to alter intrinsic risks and the major treatment modalities focus 
of alteration and correction of extrinsic risk factors. History and examination are critical in 
elucidating intrinsic and extrinsic risk factors and these factors should be corrected, wherever 
possible, to assist in alleviating symptoms and preventing injury recurrence. 
 
Differential Diagnosis of Posterior Ankle/ Heel Pain
Bony 
Fracture: 
os trigonum 
calcaneal stress fracture 
Severe’s disease (adolescent patients) 
  
Joint 
Tarsal coalition 
 
Soft-tissue 
Impingement syndromes 
posterior ankle impingement 
tarsal tunnel syndrome 
entrapment medial calcaneal nerves 
sural nerve entrapment 
 
Musculotendinous injury 
peroneal tendon tear/ tenosynovitis / subluxation/ dislocation 
tibialis posterior tendon tear/ tenosynovitis 
accessory soleus muscle (Figure 2) 
 
Other 
Referred pain from the lumbar spine 
Rheumatic disease, especially rheumatoid arthritis or psoriatic arthropathy 
Metabolic disease (gout, familial hypercholesterolemia)
Table 2. The differential diagnoses of patients presenting with posterior heel pain or ankle 
pain. 
4. Clinical features of achilles tendinopathy 
Thorough history and examination is the cornerstone of diagnosis in medicine, and this 
must be the first step in assessing the Achilles tendon. This is to ensure that the correct 
diagnosis is made and that risk factors are addressed in the management program to 
optimize treatment outcomes. 
4.1 History 
Achilles tendinopathy is relatively common in weightbearing athletes with rates between 5-
20% reported in runners. It is a common injury presentation in runners, track and field 
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athletes, and all football players. The classic presentation of Achilles tendinopathy is the 
insidious onset of posterior heel or calf pain over a few months. There may be pain, 
swelling, and impairment of function. It may have a relapsing and remitting course with 
improvements during periods of rest from heavy weightbearing activity.  
 
Fig. 2. MRI sagittal image of an accessory soleus muscle (green arrow) that is easily 
differentiated from the Achilles tendon (red arrow). The space occupying effect of this 
accessory soleus muscle can mimic symptoms of Achilles tendinopathy but also the features 
of posterior ankle impingement. 
Referring to the work of Blazina et al, initially there may be pain in the tendon with the 
onset of weightbearing activity such as running, but the tendon pain resolves with 
continued running (the tendon “warms”). As the Achilles tendinopathy worsens, there may 
be aching after activity. With increasing use and tendon degeneration the pain may continue 
during the course of all weightbearing activity and may eventually preclude heavy 
weightbearing activity due to the level of pain. Morning pain and stiffness is a common 
feature of Achilles tendinopathy. Achilles tendon swelling may be noted by the patient, but 
it is rare to have mechanical symptoms or instability. History should ascertain if there have 
been any previous lower limb injuries, especially to the ankle, and also if the patient has 
other medical problems, is taking medication, or if there is a family history of rheumatic 
disease. Any treatment that the patient has had should be recorded and also if these 
treatments assisted with the symptoms or not. 
4.2 Examination 
On examination the examination should generally proceed in a structured manner to assess 
for the correct diagnosis, appropriate risk factors, and signs of differential diagnoses. Lower 
limb biomechanics should be assessed with standing and walking. In athletes it may e more 
www.intechopen.com
 Achilles Tendon 
 
80
appropriate to assess this with video monitoring of treadmill running or on-field training. 
With the patient in a standing position the examination should include assessment of foot 
biomechanics such as pes planus or pes cavus and subtalar hyperpronation, weightbearing 
ankle range of motion (ROM) including ability to perform single leg heel raise, general 
lower limb alignment such as genu varum or valgum, dynamic pelvic stability with 
Trendelenberg testing, and lumbar spine ROM and symptoms referral. Gait examination 
should assess for antalgic gait, reduced ankle or knee ROM, and Trendelenberg gait. With 
the patient sitting, perform neural tension tests such as the slump test and look for hand and 
nail changes of psoriasis. The patient should then be positioned supine and assessed for leg 
length discrepancy, lower limb neurology, and joint ROM (this must include assessment of 
ankle joint, subtalar joint, and 1st metatarsophlangeal (MTP) joint, but should also include 
assessment of knee and hip joint ROM) laxity, especially lateral ankle laxity with anterior 
drawer test for anterior talofibular ligament (ATFL) laxity and talar tilt test for 
calcaneofibular (CF) ligament laxity. Ankle plantarflexion and dorsiflexion strength, as well 
as 1st MTP joint flexion and extension strength, and also foot eversion and inversion strength 
should be assessed. Tinel’s test over the tarsal tunnel and medial calcaneal nerves can be 
performed in the supine position. The patient may then be positioned prone for inspection 
of calf muscle bulk and tone, as well as any Achilles or retroAchilles swelling. Swelling and 
tendon thickening may be obvious either at the Achilles insertion, where bursitis or 
calcaneal bony protruberences may occur, or 4-6 cms proximal to this at the classic site of 
non-insertional Achilles tendinopathy (Figure 3). 
 
Fig. 3. The clinical manifestation of non-insertional Achilles tendinopathy is indicated by the 
arrow. There is obvious tendon thickening in the region 4-6 centimetres from the calcaneal 
insertion when compared with the other side, and this area will be tender to palpation. The 
tenderness may be reduced with the tendon placed under stretch by passive ankle 
dorsiflexion and re-palpation (London test). 
Tenderness will generally be well localized to these two sites and tenderness may be 
reduced by placing the tendon under stretch with passive ankle dorsiflexion (London test). 
An assessment of tendon gliding function and crepitis may be performed in cases on non-
insertional Achilles tendinopathy. Palpation of the retroAchilles space should be performed 
to assess for tenderness immediately deep to the distal Achilles tendon suggestive of 
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retrocalcaneal bursitis, fullness or tenderness within the space suggestive of posterior ankle 
impingement, accessory soleus muscle, or other space occupying lesion. Palpation should 
also be performed over the tibialis posterior tendons medially and peroneal tendons 
laterally and strength testing performed particularly with regard to assessing for peroneal 
tendon subluxation or dislocation. Posterior ankle impingement sign should be checked, 
and calcaneal squeeze test performed to exclude calcaneal stress fracture. 
This examination should allow the examiner to determine with confidence the presence or 
absence of Achilles tendinopathy, the site of Achilles tendinopathy and any associated 
features, intrinsic and intrinsic risk factors, and also exclude the common differential 
diagnoses for posterior heel pain. 
5. Investigations 
Achilles tendinopathy is essentially a clinical diagnosis and investigations are generally only 
required to exclude other pathology around the ankle or calf. Xrays may delineate bony or 
joint problems such as acute or stress fractures, os trigonum, or tarsal coalition, and may 
show the presence of tendon calcification that should alert the clinician to suspicion or 
rheumatic or metabolic disease. Lateral ankle Xray may also be used to assess for Haglund’s 
deformity which may be associated with insertional Achilles tendinopathy. Blood tests for 
rheumatic disease and urate levels may be considered. Magnetic resonance Imaging (MRI) is 
an excellent investigation for showing the presence or absence of soft-tissue pathology 
around the ankle and will generally delineate Achilles tendon pathology. 
Asymptomatic tendon degeneration is common and should be considered when performing 
any investigation on the Achilles tendon. With either ultrasound (Figure 4) or MRI the 
Achilles tendon ultrastructure can be assessed for tendon fusiform thickening, fibre 
disruption, and fluid within or around the tendon, including bursitis. These investigation 
findings should be accurately correlated with the site of clinical examination findings before 
ascribing the diagnosis and classification of Achilles tendinopathy. Doppler ultrasound is an  
 
Fig. 4. Ultrasound image showing an Achilles tendon partial tear with hypoechoic region 
(green arrow). 
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extremely useful adjunct investigation for Achilles tendinopathy and may show 
neovascularisation, or active bursitis. Note that in the early stages of symptoms there may 
be no changes noted on investigation. 
6. Non-surgical management of achilles tendinopathy 
Treatment of all musculoskeletal injuries can involve non-surgical or surgical therapies. 
Non-surgical management of Achilles tendinopathy, whether insertional or non-insertional, 
is similar and generally involves symptom control, correction of risk factors, stretching and 
exercise rehabilitation, and therapeutic injections. Correction of intrinsic and extrinsic risk 
factors is a critical element of management to assist in decreasing abnormal load on the 
Achilles tendon, decreasing symptoms, and minimizing the risk of recurrence. Grading of 
tendinopathies is not generally clinically useful, however partial tears in the Achilles tendon 
will often take longer for symptoms to resolve. It is commonly stated that insertional 
Achilles tendinopathy is more recalcitrant to treatment, and this may be due to traction 
effects and calcification at the insertion (Figure 5). 
 
Fig. 5. Insertional Achilles tendinopathy is often more recalcitrant to treatment than non-
insertional Achilles tendinopathy, and this may be due to traction effects and calcification at 
the insertion (green arrow). Note the bony oedema adjacent to the tendon insertion. Discrete 
foci of calcification may require debridement surgery if symptoms persist despite non-
surgical therapies. 
6.1 Symptom control 
Pain is generally the dominant symptom in Achilles tendinopathy and may be managed 
using regular icepack application 15 minutes per time throughout the day. This may be 
particularly effective after exercise. Physical therapy treatment with electrotherapeutic 
modalities such as therapeutic ultrasound or interferential treatment may assist in 
decreasing pain, as may gentle transverse friction massage. Relative rest is preferred and 
this involves the avoidance of all aggravating activities, where possible. An aggravating 
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activity includes any activity that cause tendon pain during the activity, tendon pain after 
the activity, or increased tendon pain and stiffness the morning after an activity. To avoid 
aggravating activites it may be necessary to avoid weightbearing exercise and to cross-train 
with painfree non-weightbearing exercise such as cycling, rowing/ kayaking, or swimming. 
Analgesics can be used to control strong pain and paracetamol/ acetaminophen is the 
preferred analgesic. Non-steroidal anti-inflammatory drugs (NSAIDs) should only be used 
where the condition is inflammatory in nature. The use of NSAIDs should be considered in 
early symptoms of Achilles tendon pain (the initial 2-3 weeks of symptoms), although it is 
uncommon for patients to present for medical care at this stage of symptoms. NSAIDs are 
more commonly used where bursitis, retrocalcaneal or retroAchilles, is associated with 
insertional Achilles tendinopathy or where paratenonitis is demonstrated to be associated 
with non-insertional Achilles tendinopathy. Topical agents will be discussed later in the 
chapter. 
6.2 Correction of intrinsic risk factors 
6.2.1 Biomechanics of the lower limb 
Intrinsic risk factors such as lower limb biomechanical issues can generally be corrected 
through the use of shoes or orthotics and referral for podiatric assessment may be required. 
The critical element of correcting biomechanical issues is to achieve sustained control of the 
hindfoot. Good quality supportive footwear is one aspect of this but orthotic correction is 
imperative in patients with pes planus and also those with functional hyperpronation 
(Figure 6).  
 
Fig. 6. Photograph of a female with subtalar hyperpronation in stance phase. Note the 
prominence of the medial aspect of the arch. Also note the long second toe (Morton’s foot 
type). 
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Taping the handfoot and assessing the response to a patient’s pain is one way to 
determine if orthotic prescription is likely to be beneficial for the patient. Assessing the 
shoes for abnormal wear patterns and for friction over the Achilles tendon is also 
important to determine possible causative factors in the patient’s symptoms. Wedged lift 
heel raise devices are advocated to unload the Achilles tendon through simple 
biomechanical processes, but these do not control the hindfoot. Heel lift wedges should be 
worn at all times early in the treatment of Achilles tendinopathy and must be worn in 
both shoes to avoid asymmetry in gait. Any recognized leg length discrepancy over 1 cm 
should be corrected through built up orthotics or shoes. Before correcting this it is 
suggested that a more accurate determination of leg length difference is performed and a 
single shot scout Computerised Tomography (CT) scan can better determine this using 
digital calipers. 
6.2.2 Joint asymmetry 
Restrictions in joint range of motion can also lead to disturbance of the kinetic chain and 
create force imbalance between sides. The major joints that require assessment are the 1st 
metatrophalangeal (MTP) joint, midtarsal joints, subtalar joint, ankle joint, knee joint and 
hip joint. Any restriction in joint range of motion can potentially increase the load on the 
Achilles tendon and range of motion exercises as well as active and passive joint 
mobilization is required as therapy. 1st MTP joint stiffness is commonly found in patients 
with Achilles tendinopathy and, again, may contribute to the onset of the condition or is 
caused by the condition. Stretching the 1st MTP and massage through the central plantar 
fascia can assist in normalizing joint range of motion, but toe flexion exercises should also be 
incorporated into the treatment program to ensure adequate 1st MTP joint strength and 
endurance as this is a critical aspect of the gait cycle with 1st MTP joint flexion largely 
contributing to the push-off phase of walking or running. 
In athletes, especially those performing unilateral upper body movements, such as tennis 
players, volleyball players, or throwing athletes, it is important to assess shoulder range of 
motion, and also trunk and thoracic spine range of motion in rotation.  
6.2.3 Joint instability 
There are two causes of joint instability, hereditary such as with generalized liagmentous 
laxity, and traumatic. Generalized liagmentous laxity is a recognized hereditary 
predisposition to joint laxity and is characterized by knee recurvatum, lumbar spine 
ligamentous laxity (as can be demonstrated by the patient being able to stand and forward 
flex the lumbar spine to place their palms onto the floor), laxity in elbow joints with 
hyperextension, and laxity in finger and thumb metacarpophalangeal (MCP) joints 
(demonstrated by 5th finger MCP joint extension beyond 90 degrees, and by flexing the wrist 
and then touching the thumb to the volar aspect of the forearm) as per Beighton’s criteria. 
Traumatic instability to joints distal to the Achilles tendon in the kinetic chain are generally 
more commonly identified contributing risk factors than joints proximal to the Achilles 
tendon. These joints and joint injuries include the 1st metatarsophalangeal joint and 1st toe 
flexor dysfunction, and the ankle joint and previous lateral ligament sprains and peroneal 
tendon weakness, or peroneal tendon subluxation/ dislocation. Essentially, both joint laxity 
and joint instability contribute to the causation of Achilles tendinopathy by increasing load 
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onto the Achilles as a the primary ankle plantarflexor, or increasing the necessity of the 
Achilles tendon acting to assist as an ankle joint stabilizer. Often strengthening exercise is 
effective as therapy for joint instability to control joint motion, but in cases of gross laxity 
with functional instability, such as with peroneal tendon subluxation/ dislocation, surgery 
may be necessary to restore joint stability and function. 
6.2.4 Rheumatic and metabolic disease 
Patients with hereditary rheumatic diseases such as rheumatoid arthritis or psoriatic 
arthritis may have tendon abnormalities manifesting as part of the systemic disease 
process. In rheumatoid arthritis these tend to be nodular Achilles tendon abnormalities, 
whereas in psoriatic arthropathy the Achilles tendon manifestation is more likely to be 
exuberant tendon calcification, particularly adjacent to the Achilles tendon insertion. 
Metabolic diseases can also present with tendon manifestations such as the crystal 
deposition of gout, or the lipid tendon xanthomata associated with familial 
hypercholesterolaemia. These systemic diseases cannot truly be cured, and the 
management of the tendon manifestations is through control of the generalized disease 
process. Large tendon nodules or xanthomata may need surgical excision to restore 
appropriate gliding function of the Achilles tendon. 
6.3 Correction of extrinsic risk factors 
6.3.1 Training errors 
One of the most common extrinsic risk factors for Achilles tendinopathy in active people is 
training errors. This often comes do to a lack of knowledge of basic training principles such 
as adequate warm-up and stretching before exercise, graded increases in training, adequate 
recovery time through rest days, and appropriate cross-training . A key aspect of preventing 
injury in sports is to have adequate warm-up and stretch prior to exercise. This ensures that 
the musculotendinous units are at an appropriate functional length and this should allow 
for exercise with minimal risk of injury. Specifically for the Achilles tendon it is essential 
that stretching is performed for both the gastrocnemius and soleus components of the calf 
musculature and this would normally take the form of a straight knee calf stretch and a bent 
knee calf stretch. 
With any level of exercise or training it is generally rapid alterations to the training program 
that lead to overload or overuse injuries and this is no different for Achilles tendinopathy. 
Common changes would include increasing the duration or frequency of training sessions, 
and thus the total training volume or load, but it may also be that changes occur in the 
intensity of training. Cross-training with different forms of exercise, including non-
weightbearing exercise, can be a useful aspect of training programs but must be performed 
with caution in athletes not familiar with weightbearing training (i.e. swimmers that 
beginning running for fitness). Starting training or exercise after being sedentary is a 
common history in patients with Achilles tendinopathy. For this same reason, resuming 
training after an absence, including an enforced absence due to injury or as part of the 
treatment for Achilles tendinopathy, requires careful planning to ensure that the training is 
not too much too soon. A recurrence Achilles tendinopathy can be avoided with simple 
advice and planning on resumption of exercise. 
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6.3.2 Surfaces and equipment 
Weightbearing exercise on certain surfaces may contribute to the causation of Achilles 
tendinopathy. Hard surfaces increase the required shock absorption for the lower limb 
musculotendinous structures, including the Achilles tendon, whilst soft or unstable surfaces 
like soft sand require the Achilles and other stabilizing tendons to increase their workload 
during exercise. Certainly, it is recognized that changes in the surface on which 
weightbearing exercise is performed can contribute to the aetiology of Achilles 
tendinopathy. This can be from hard to soft surfaces or vice versa, from sprung flooring to 
unsprung flooring, or from treadmill running to road running. In the same way, changes to 
exercise on hills, or on slopes or cambered surfaces can also contribute to the development 
of Achilles tendinopathy. This may be caused by simple changes in running routes or by 
beginning to run on cambered roads rather than flat running tracks. Changes in running 
footwear may contribute to causation in Achilles tendinopathy due to different properties of 
the shoes such as level of foot control or shock absorption. All of these factors should be 
investigated in the history and addressed in management of Achilles tendinopathy. 
6.3.3 Nutrition 
Fatigue is often cited as a potential cause of tendinopathy and may contribute through loss 
of joint or muscle control leading to increased forces acting on the Achilles tendon. Ensuring 
adequate hydration and energy availability to working muscle during exercise is critical to 
minimizing fatigue. Again, simple preparation should ensure that adequate fluid intake and 
carbohydrate intake is maintained before, during, and after exercise. 
6.3.4 Medications 
Certain medications may affect tendon metabolism and it is important to address previous 
and current medications to ensure that these medications are used only if absolutely 
necessary. Flouroquinolones such as the antibiotic ciprofloxacin have been implicated in 
Achilles tendon ruptures and appear to have a detrimental affect on tendon metabolism. 
Anabolic steroids have also been suggested as a cause of tendon rupture, possibly due to the 
rapid increase in muscle strength before the tendon has completed its strength adaptations. 
Anabolic steroids are illegal in many countries but their use is widespread nonetheless and 
this needs to be addressed in taking a history from the patient. 
6.4 Exercise rehabilitation for achilles tendinopathy 
6.4.1 Stretching 
Exercise rehabilitation through muscle stretching and eccentric exercise is accepted as the 
mainstay of therapy for Achilles tendinopathy. The timeframe of recovery for symptom 
resolution in Achilles tendinopathy is in the order of 2-3 months at a minimum and both the 
patient and the medical practitioner need to appreciate this timeframe and commit to 
treatment over this period. Although stretching is advocated by most medical practitioners 
as part of the treatment regime, very little evidence is available to support this, or to 
determine the best form of stretching in treating Achilles tendinopathy. Despite this, logic 
would suggest that the aims of treatment with stretching are to restore musculotendinous 
unit length and thus static prolonged stretching should best achieve this aim. Stretching 
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both the gastrocnemius muscle, through straight knee calf stretching, and also the soleus 
muscle component, through flexed knee calf stretching, is important to ensure that all 
components of the Achilles musculotendinous unit are incorporated in the stretching 
program. Stretching to the point of pain is generally discouraged and, especially in 
insertional Achilles tendinopathy, may be counterproductive and continue to irritate the 
symptoms and prolong recovery time. Any recognized muscle asymmetry also requires 
correction through stretching and a general lower limb stretching program should be 
considered. The kinetic chain relationship between the 1st metatarsophalangeal joint in toe 
flexion with toe “push-off” and the Achilles musculotendinous unit as an ankle 
plantarflexor and stabilizer in this gait phase is appreciated and requires that 1st 
metatarsophalangeal joint range of motion is optimal to assist in managing load through the 
Achilles tendon. Thus, stretching the 1st metatarsophalangeal joint is a critical part of 
management of Achilles tendinopathy. 
6.4.2 Exercise rehabilitation 
Again it is worth emphasizing that exercise rehabilitation through muscle stretching and 
eccentric exercise is accepted as the mainstay of therapy for Achilles tendinopathy. 
Numerous studies have demonstrated the symptom reduction achieved through eccentric 
exercise protocols in Achilles tendinopathy. Irrespective of other treatments used or 
considered in the treatment of Achilles tendinopathy, eccentric exercise must form an 
integral part of the treatment program in this condition.  
Tensile loading of musculotendinous units stimulates tendon healing along appropriate 
lines and directions of force and allows the tendons to achieve the necessary strength and 
endurance required to accept loading with weightbearing activity. This tensile loading 
appears to be best achieved through eccentric exercise protocols. The type of eccentric exercise 
is similar for both insertional and non-insertional Achilles tendinopathy but the range of 
motion in the eccentric phase differs to achieve the best symptom reduction in each specific 
type of Achilles tendinopathy. Alfredson et al (Alfredson , 1998) demonstrated that eccentric 
exercise is effective in reducing pain in Achilles tendinopathy and is as effective as surgical 
treatment for symptom reduction (Figure 7). This group showed that heavy-load eccentric 
exercise could reduce pain levels form an average of 7 out of 10 to an average of 3 out of 10. It 
is important to recognize that few patients became completely asymptomatic with this 
treatment regime alone.The eccentric exercise involved heel-drop exercises off a step, with 
the forefoot only on the step and, as would be expected, two forms of eccentric exercise were 
used, one with the knee flexed and one with the knee straight in order to load both the 
soleus and gastrocnemius components of the Achilles musculotendinous unit. The protocol 
of heavy-load eccentric exercise used in this landmark study involved twice daily heel-drop 
exercises with three sets of 15 repetitions with a flexed knee and three sets of 15 repetitions 
with a flexed knee. This is a combined total of 180 heel drop exercises. This protocol is time 
consuming but is recognized as the appropriate level of eccentric exercise required to 
achieve a symptom reducing effect. It is critical to note that there is no active concentric, or 
muscle shortening, phase of the exercise and recovery of ankle position needs to be assisted 
either by weightberaing on the other leg or, preferably, by using the arms to pull up on a 
stair rail or other fixed structure to recover ankle position. Neisen-Vertommen et al (Neisen-
Vertommen, 1992) further demonstrated that eccentric exercise alone was more effective the 
concentric-eccentric exercise and this is the reason that it is important to minimize, or. 
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Fig. 7. Eccentric heel drop exercises using a stair or step. The forefoot is on the step with the 
midfoot and hindfoot unsupported. The heel is then lowered and an eccentric exercises 
component will generated (tendon lengthening under load). This eccentric exercise is the 
core component of exercise therapy for Achilles tendinopathy. 
abolish, any active concentric exercise component in the heel-drop exercise rehabilitation. 
Eccentric exercise rehabilitation for non-insertional Achilles tendinopathy should be 
performed is a slow and controlled manner and the heel should generally reach below the 
horizontal level of the step With the knee flexed, the heel will not reach far below this 
horizontal level. There is no benefit from holding the exercise at this end-range as the 
presumed benefit of eccentric exercise is the tensile lengthening of the musculotendinous 
unit under weightbearing load. Recent research suggests that in the treatment of insertional 
tendinopathy the heel drop exercises should be performed is a slow and controlled manner 
and the heel should not reach below the horizontal level of the step. This may allow for the 
tensile forces to act on the musculotendinous unit whilst also minimizing the traction effect 
on the Achilles tendon insertion.  
6.5 Topical medications 
6.5.1 Topical glyceryl trinitrate 
Glyceryl trinitrate has a long history of therapeutic use, being discovered as an effective 
treatment of angina pectoris in miners handling the explosive nitroglycerin in the 1870’s. 
The mechanism of action of topical glyceryl trinitrate is suggested to be through the 
biologically active metabolite nitric oxide, also termed endothelial derived relaxing factor, 
due to the vasodilatory action of this metabolite. In animal studies, the addition of nitric 
oxide to injured tendon was demonstrated to improve tendon healing, although the exact 
mechanism of this action is not clear. It may be an analgesic effect, an effect on global tendon 
bloodflow, or an effect on the tendon neovessels seen as a histopathologic response in 
degenerative tendinopathy. As a result of the basic science research into topical glyeryl 
trinitrate, studies were performed to assess the effect of topical glyeryl trinitrate in symptom 
reduction in non-insertional Achilles tendinopathy [Paoloni, 2004]. This randomized 
controlled clinical trial demonstrated significant pain reduction, increase in object tendon 
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strength measures, and an increased rate of patients being completely asymptomatic after 
six months of treatment. The topical glyeryl trinitrate was applied as a patch (Figure 8) over 
the symptomatic tender area of the Achilles tendon and was used in continuous dosage.  
 
Fig. 8. The topical glyceryl trinitrate patch used in clinical trials to effectively treat the 
symptoms of non-insertional Achilles tendinopathy. This patch is one quarter of a 5mg/ 24 
hour (0.2 mg/ hour) NitroDur® patch (manufactured by Schering-Plough Australia), 
howver similar drug dosages can be achieved with other glyceryl trinitrate patches or 
ointments. 
The continuous dosage regime was designed to minimize the frequency and severity of 
side-effects through tolerance to the vascular side-effects of the patch, as opposed to the 
“drug holiday” regime used in cardiovascular medicine where there is a need to maintain 
vascular sensitivity to nitric oxide to ensure adequate vasodilatation. The side-effects of 
topical glyeryl trinitrate include headache and rash and approximately 5-10% of patients 
will not tolerate the patch usage to treat Achilles tendinopathy due to these problematic, but 
reversible, side-effects. It must be emphasized that the topical glyeryl trinitrate treatment is 
used in addition to exercise rehabilitation. Topical glyceryl trinitrate treatment, especially 
continuously, is contraindicated in patients with known cardiovascular disease, especially 
angina pectoris, due to the potential development of tolerance to topical glyceryl trinitrate 
vasodilatation effects. 
6.5.2 Topical anti-inflammatory medications 
As symptom relief is an important aspect of the treatment of Achilles tendinopathy, there 
may be a role for topical anti-inflammatory medications to treat Achilles tendinopathy, 
especially insertional Achilles tendinopathy associated with retrocalcaneal or retroAchilles 
bursitis. These topical anti-inflammatory agents may take the form of non-steroidal anti-
inflammatory drugs (NSAIDs) such as diclofenac or piroxicam creams, or may be other 
medications such as traumeel®, an interesting semi-homeopathic preparation containing 
measurable amounts of multiple natural substances such as arnica and Echinacea, and having 
shown evidence of anti-inflammatory properties mainly in treating gastrointestinal disorders. 
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6.6 Injection therapies in achilles tendinopathy 
6.6.1 Corticosteroid and anti-inflammatory injections 
Corticosteroids are catabolic steroids that have anti-inflammatory properties and are 
widely used in musculoskeletal medicine. In weightbearing tendons, such as the Achilles 
or patellar tendon, there is a theoretical risk of tendon rupture after corticosteroid 
injections. This may be due to the catabolic effect of corticosteroids, with a transient 
weakening of tendon substance, it may be due to the incorrect placement of the injection 
into the tendon substance creating pressure necrosis and catabolic effects, or it may be 
due to the pre-existing degenerative process in the tendon that has already weakened the 
tendon substance. Few studies have assessed the effect of corticosteroids in the treatment 
of Achilles tendinopathy, however one study [Da Cruz, 1988] using ultrasound guided 
corticosteroid injection into the Achilles paratenon in non-insertional Achilles 
tendinopathy did not show any statistically significant improvement. This may be due to 
the degenerative nature of the pathologic process in chronic Achilles tendinopathy, 
although it is conceivable that this treatment may be effective in the first few weeks of 
symptoms of Achilles tendon pain, when an acute inflammatory response may be present. 
Corticosteroid injections may be more useful as therapeutic agents where retrocalcaneal 
bursitis (Figure 9) or retroAchilles bursitis is present with insertional Achilles 
tendinopathy. The indications for using corticosteroid injections are generally for 
decreasing severe pain to allow the patient to perform exercise rehabilitation relatively 
pain free, or when there is a plateau in any improvement with exercise rehabilitation. 
These injections are best performed guided to minimize the risk of intratendinous 
injection and thus potential tendon rupture. With ultrasound visualisation the fluid in the 
distended bursa may be seen, under Doppler ultrasound increased vascularity in the 
bursa may be appreciated, and the injection can also be seen to be in the bursa with bursal 
filling demonstrated. 
 
Fig. 9. MRI sagittal image showing retrocalcaneal bursitis (arrow). This may be effectively 
treated using injected corticosteroid agents. 
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Where there is a suggestion that pain is potentially caused by inflammation, such as in non-
insertional Achilles peritenonitis or where the pain is at the level 4-6 cms above the tendon 
insertion but there are nil ultrastructural changes or abnormal vascularity in this region, or 
at the Achilles insertion with associated retrocalcaneal or retroAchilles bursitis, and there is 
a concern about possible tendon rupture with the catabolic effect of corticosteroid injection, 
then other anti-inflammatory agents such as traumeel® injection may be considered. This 
may be the case where active patients or athletes will not be able to unload the tendon after 
injection. Any symptom relieving effect of traumeel® injection in this circumstance may be 
due to a dilution effect of any chemical irritation at the site of pain. 
6.6.2 Polidocanol sclerotherapy injections 
Polidocanol is a sclerosant medication that has predominantly been used to treat venous 
varicosities. However, studies have demonstrated a positive therapeutic effect in treating 
Achilles tendinopathy through the use of Doppler ultrasound guided polidocanol injections 
[Ohberg, 2002], and this effect appears to persist at 2 year follow-up[Lind, 2006]. Ohberg et 
al reported that the pain reducing effect was in the order of 80% pain reduction in 
approximately 80% of patients when using between one and five guided polidocanol 
injection sessions. The procedure involves assessing the Achilles tendon for increased 
vascularity under Doppler ultrasound, compared to normal tendon substance that does not 
show any vasuclarity under Doppler ultrasound (Figure 10). The vascularity is believed to 
be due to neovascularisation, part of the pathologic process of degenerative tendinopathy. It 
is relatively common to view a single vessel, or a few vessels, entering the tendon from the 
deep aspect and then branching more widely throughout the tendon substance. To avoid 
pressure necrosis it is best to attempt to sclerose the vessels at the tendon undersurface and 
use as small an amount of polidocanol sclerosant as is possible. The more accurately the 
needle tip can be visualized the better the sclerosant effect and the less infiltrate that will be 
 
Fig. 10. Colour Doppler ultrasound image showing the Achilles tendon (green arrow marks 
the Achilles tendon) with thickening of the tendon, a hypoechoic region suggestive of small 
partial tendon tear, and prominent vascularity. The vascularity often appears to enter from 
the undersurface of the tendon (pink arrow) and then branch through the tendon. Sclerosing 
the vascularity at the entry point to the tendon can be an effective treatment for symptom 
reduction. 
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required during the procedure. This takes experience but should allow immediate abolition 
of the vascularity in the tendon as visualized in real-time under Doppler ultrasound. The 
effect can be quite impressive, but is not always complete. Repeating the procedure may be 
required if pain is not decreased or abolished. As reported in the initial study on 
polidocanol sclerotherapy [Ohberg, 2002], it may take several injections to achieve adequate 
symptom resolution. There does not appear to be any negative effect on tendon structure 
with polidocanol injections and the tendon may be loaded normally within a few days after 
the injection without any apparent risk. If bursitis is found to be associated with increased 
tendon vascularity, then it is recommended that polidocanol injections be used to sclerose 
the neovessels and corticosteroid is infiltrated into the inflamed bursa during the same 
ultrasound procedure. This may then require 5-7 days of rest before returning to normal 
tendon loading, in order to allow the corticosteroid to have an effect on the bursal 
inflammation. 
6.6.3 Prolotherapy injections 
Prolotherapy, or “proliferation therapy”, is a term that is generally applied to various non-
pharmacologic injection types all of which are proposed to act to strengthen weakened 
degenerative connective tissue in tendon presumably by an irritant effect. There are mostly 
used at insertions of tendons or ligaments. The types of solutions vary but commonly used 
injection types include glucose, local anesthetics such as lidocaine, phenol, or glycerine. In 
most medical practices it is the relatively innocuous injections such as glucose and lidocaine 
that are used due to the low side-effect profile. Prolotherapy injections may be considered, 
after weighing the risks and benefits of these, for recalcitrant insertional Achilles 
tendinopathy. Again, a period of rest is probably required after the injection and then 
continuance of exercise rehabilitation program. 
6.6.4 Autologous blood product injections 
Autologous blood products have been used as injection therapy in musculoskeletal 
medicine for many decades. This may be in the form of autologous blood or as blood 
extracts such as platelet rich plasma (PRP) or isolated specific growth factors such as 
fibroblast growth factor or platelet derived growth factor. The therapeutic use of isolated 
growth factors for specific musculoskeletal injury is still in its infancy, and is currently 
prohibited for competitive athletes under the World Anti-Doping Authority (WADA) code 
January, 2011. The evidence for the use of autologous blood products, including platelet rich 
plasma, to treat Achilles tendinopathy or other tendinopathies is scant and most well 
conducted clinical trials do not show evidence of effect [de Vos, 2010 and Paoloni, 2010]. 
However many facets of the use of these injections have not been established, including; 
what is the optimal blood product injection type, what is the optimal volume of injection, 
what is the optimal timing of injection after injury, what is the optimal number and spacing 
of injections (single injection versus injection series, and what the optimal rehabilitation is 
after injection. These autologous blood product injections are probably best used for cases of 
recalcitrant insertional Achilles tendinopathy where they may have an irritant or 
proliferative effect similar to that of prolotherapy injections. The risks and benefits need to 
be weighed before deciding on these injections, but the side-effect profile is low, with post-
injection pain and irritation for up to 1-2 weeks the most likely side-effect. The irritant side-
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effects may be greater if these products are injected into the tendon substance rather than 
around the tendon. 
6.6.5 Mesotherapy injections 
Mesotherapy is widely practiced in sports medicine and refers to the use of multiple 
injections, often of anti-inflammatory medications such as piroxicam, into the subcutaneous 
fat overlying a region of musculoskeletal pain. The evidence for this treatment is also scant 
and the mechanism of effect appears unclear but may be due to localised tissue uptake of 
anti-inflammatory medication. This treatment may provide symptomatic relief especially in 
insertional Achilles tendinopathy associated with retrocalcaneal or retoAchilles bursitis. 
Mesotherapy is generally performed as a series of three sessions of multiple subcutaneous 
injections over a three week period.  
7. Surgical treatment for achilles tendinopathy 
Surgical treatment for Achilles tendinopathy is generally reserved for recalcitrant cases 
where non-surgical management has failed to provide effective symptom relief or ability to 
function in daily life or in sporting activities. It is often dictated by the patient who may 
become frustrated by continued symptoms despite long periods of exercise rehabilitation 
and also trials of injections and other therapies. It is reported that between 24% and 46% of 
patients with Achilles tendinopathy eventually require some form of surgical treatment, 
however this rates appears quite high and may represent the incidence of surgery in 
patients presenting to orthopaedic surgeons [Maffulli, 2002]. Many patients with Achilles 
tendinopathy may never consult a surgical specialist for their condition. It must be 
recognised that probably 10-20% of patients with Achilles tendinopathy continue to have 
symptoms in the longer term and it is this population that would be considered for surgical 
treatment. Conditions such as chronic bursitis, especially associated with Haglund’s 
deformity, may require surgery (Figure 11). 
7.1 Tendon surgery 
The exact surgical procedure used to treat Achilles tendinopathy varies amongst surgeons 
and geographical regions but will generally involve; tendon debridement and bursal 
resection, if required. The tendon debridement may take the form of multiple longitudinal 
incisions into the Achilles tendon substance with or without curettage of any mucoid 
degenerative areas, or may be less invasive and involve debridement of the tendon surface 
and paratenon only. Any bursal involvement at the Achilles insertion should warrant bursal 
resection. The majority of patients will experience symptom reduction after surgery, 85% of 
patients report good results after surgery, and many patients will be able to return to previous 
level of activities or sport within six to twelve months post-surgery whether surgery is 
performed with open procedures [Saxena, 2003] or less invasive methods [Maffull, 1997]. 
7.2 Surgery procedures for bony abnormalities 
There may be bony abnormalities that contribute to the development of Achilles 
tendinopathy and these may nee to be addressed surgically. Surgery may be only to rectify 
these bony abnormalities or it may be in combination with tendon debridement surgery. 
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Fig. 11. Chronic fat pad inflammation, Haglund’s deformity (arrow) and insertional Achilles 
tendinopathy. This case may require surgery for ongoing symptoms. Also note the 
osteopoikilosis, a benign condition manifesting as dark bone islands on MRI. 
Haglund’s deformity is a posterosuperior bony calcaneal protruberance that may 
predispose to both retrocalcaneal bursitis and to insertional Achilles tendinopathy due to a 
mechanical friction effect on the deep surface of the Achilles tendon (Figure 8). If Haglund’s 
deformity is present and there is concomitant recalcitrant Achilles tendinopathy then it may 
be necessary to perform surgical excision of the Haglund’s deformity. Sever hindfoot 
abnormalities with hindfoot varus may also predispose to Achilles tendinopathy through a 
twisting or “wringing out” mechanism of the collagen fibres and microvasculature. 
Correction of moderate flexible hindfoot varus caused by subtalar hyperpronation may be 
achieved through footwear and orthotics as discussed earlier, however severe hindfoot 
varus or fixed hindfoot varus may require surgical correction through calcaneal osteotomy 
or similar biomechanic realignment procedures. 
8. Conclusion 
The aetiology of Achilles tendinopathy is complex and multifactorial and the management 
of this condition requires a thorough understanding of the extrinsic and extrinsic risks 
factors, biomechanics or the lower limb and the concept of the kinetic chain. Management of 
Achilles tendinopathy, whether insertional or non-insertional, should always be non-
surgical initially, and must focus on elements of pain control, correction of intrinsic and 
extrinsic risk factors, and exercise rehabilitation through appropriate stretching and 
eccentric exercise protocols. Other modalities such as topical or injected medications may be 
required if pain is not controlled or if symptomatic improvement with exercise 
rehabilitation plateaus. Based on stratification of risks and benefits in patients with 
recalcitrant Achilles tendinopathy, and no cardiovascular disease, a sensible approach to 
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adjunctive modalities would start with topical agents such as continuous topical glyceryl 
trinitrate treatment in addition to exercise rehabilitation. Further adjunctive treatment with 
injections differs depending on the site of Achilles tendinopathy. In both insertional and 
non-insertional Achilles tendinopathy, an assessment of the tendon is made using 
ultrasound and Doppler mode. For patients with either insertional or non-insertional 
Achilles tendinopathy who demonstrate increases in vascularity in the tendon substance at 
the site that correlates with symptoms, Doppler ultrasound guided polidocanol injections 
should be the first-line treatment to assist in alleviating symptoms. Should there be 
ultrastructural tendon abnormalities without increased tendon vascularity at the 
symptomatic tendon site in non-insertional Achilles tendinopathy, then the preferred 
injection treatment becomes less clear and options would include; autologous blood or 
platelet rich plasma (PRP) into the degenerative area of the tendon or around the tendon, or 
other injections around the tendon which would include traumeel®, prolotherapy type 
agents such as glucose or lidocaine, or indeed innocuous injection agents such as normal 
saline. 
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